1. Home
  2. PCRX vs VLRS Comparison

PCRX vs VLRS Comparison

Compare PCRX & VLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$20.56

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Controladora Vuela Compania de Aviacion S.A.B. de C.V.

VLRS

Controladora Vuela Compania de Aviacion S.A.B. de C.V.

HOLD

Current Price

$9.45

Market Cap

1.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
VLRS
Founded
2006
2005
Country
United States
Mexico
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
PCRX
VLRS
Price
$20.56
$9.45
Analyst Decision
Strong Buy
Buy
Analyst Count
6
8
Target Price
$35.33
$9.60
AVG Volume (30 Days)
1.0M
556.6K
Earning Date
02-26-2026
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.47
N/A
Revenue
$716,791,000.00
$2,990,662,000.00
Revenue This Year
$6.21
N/A
Revenue Next Year
$8.26
$11.07
P/E Ratio
$43.50
N/A
Revenue Growth
3.14
N/A
52 Week Low
$18.80
$3.49
52 Week High
$27.64
$9.99

Technical Indicators

Market Signals
Indicator
PCRX
VLRS
Relative Strength Index (RSI) 36.14 61.47
Support Level $18.80 $8.41
Resistance Level $21.12 $9.67
Average True Range (ATR) 1.25 0.36
MACD -0.33 -0.03
Stochastic Oscillator 22.98 82.36

Price Performance

Historical Comparison
PCRX
VLRS

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

Share on Social Networks: